Ara
Toplam kayıt 10, listelenen: 1-10
Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry
(Turkish Soc Cardiology, 2020)
Objective: The aim of this study was to assess the clinical characteristics of patients with heart failure and preserved ejection fraction (HFpEF) and atrial fibrillation (AF) and compare them with those of HFpEF patients ...
Rationale, Design, and Methodology of the APOLLON trial: A comPrehensive, ObservationaL registry of heart faiLure with mid-range and preserved ejectiON fraction
(Turkish Soc Cardiology, 2018)
Objective: Although almost half of chronic heart failure (HF) patients have mid-range (HFmrEF) and preserved left-ventricular ejection fraction (HFpEF), no studies have been carried out with these patients in our country. ...
Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study
(Turkish Soc Cardiology, 2019)
Objective: This study aimed to examine gender-based differences in epidemiology, clinical characteristics, and management of consecutive patients with heart failure with mid-range ejection fraction (HFmrEF) and heart failure ...
Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry
(Galenos Yayincilik, 2019)
Background: Clinical characteristics of patients with heart failure may vary geographically. However, limited data are available regarding the geographical differences of patients with heart failure and preserved ejection ...
Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study
(Elsevier Science Bv, 2019)
Background: To determine and compare the demographic characteristics, clinical profile and management of patients with heart failure with mid-range ejection fraction (HFmrEF) and heart failure with preserved ejection ...
Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study
(Lippincott Williams & Wilkins, 2016)
Background Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim ...
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
(Turkish Soc Cardiology, 2016)
Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...
Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
(Springer, 2017)
The definition of non-valvular atrial fibrillation (NVAF) is controversial. We aimed to assess the impact of valvular heart disease on stroke prevention strategies in NVAF patients. The RAMSES study was a multicenter and ...
Kapak hastalığı dışı atriyum fibrilasyonu olan hastaların başvuru anındaki durumları ve verilen tedavilerin cinsiyete göre farklılıkları: RAMSES çalışması bulguları
(2017)
Amaç: Cinsiyet atriyum fibrilasyonu (AF) yönetimini etkileyen önemli bir özelliktir. Bu çalışmada, Türkiye'de AF'si olan hastalarda cinsiyet ile ilişkili farklar araştırıldı.Yöntemler: RAMSES (ReAl-life Multicenter Survey ...
Real-world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairment
(Wiley, 2017)
BackgroundThe data regarding stroke prevention strategies in nonvalvular atrial fibrillation (NVAF) are limited especially in patients with renal impairment (RI). We sought to evaluate management dilemmas in patients with ...
